Commercialization
Since we have many DNDN shareholders here, I think we are about to see the commercialization parallels begin. Both DSCO and DNDN had a terrible time with the FDA getting approval. When that happened in the case of DNDN, shareholders thought Utopia was in sight. They were wrong. While it is not a given in the case of DSCO, the warning signals are there. DSCO spent the farm (and then some) getting approval. They do not have the funding to roll this product out. Whatever the source for those funds, they are going to come dearly. Perhaps a quick buy out would be in the best interests of all. It is probably a safe bet that after the initial price pop, the shorts will be all over this knowing that more dilution is coming.